Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent Anti-Fibrotic Activity in NASH and CKD Studies
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, is pleased to report that its lead drugs for non-alcoholic steatohepatitis (NASH)... Read More
Researchers Identify Prime Compound Candidates for New Room Temperature Semiconductor Radiation Detectors
Nuclear power plants can withstand most inclement weather and do not emit harmful greenhouse gases. However, trafficking of nuclear materials to furnish... Read More
UF Health Shands Hospital Ranks Among Nation’s Best in Seven Medical Specialties
No other Florida hospital has more than seven adult specialties ranked in the nation’s top 50, up from six ranked specialties a... Read More
UF and FSU Receive $29 Million to Speed Discoveries Leading to Better Health
The University of Florida Clinical and Translational Science Institute, in partnership with Florida State University, has been awarded $29 million to speed... Read More
10 Best Values in Public Colleges, 2019
The University of Florida was ranked on the annual list of best public college values. The institutions that earn top honors on... Read More
Nathan Crabbe: Innovation Square Is Still a Work in Progress
Ten years after the University of Florida launched plans to transform the area between its campus and downtown Gainesville into a center... Read More
Researchers: Thin, Silver Nanowires May Hold Key to Flexible and Safe Touchscreens
As manufacturers seek to transition from rigid touchscreen displays, which use brittle indium tin oxide, to flexible ones that can bend, roll... Read More
Pheromones Give Nematodes a Boost in Controlling Pests
UF Innovate alumni startup Pheronym, an ag-biotech pest control company that develops and produces nematode pheromones that can be used to direct... Read More
US Biotech Startup Eyes 2020 Avian Necrotic Enteritis Vaccine Launch
Founded in 2015, UF startup Curtiss Healthcare commercialized UF researcher Dr. Roy Curtiss III’s research into orally distributed Salmonella vector vaccines. The... Read More
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study
UF startup and UF Innovate│Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated... Read More
